loader
Page is loading...
Print Logo Logo
Kendall Millard
OVERVIEW

Kendall Millard

Partner

Indianapolis

11 S. Meridian Street
Indianapolis, IN 46204-3535

P 317-231-7461

F 317-231-7433

Co-chair of the Antitrust and Competition Law practice, Kendall Millard focuses on the resolution of complex antitrust, class action and other high-stakes commercial litigation. He represents multinational corporations, including Japanese companies and their U.S. subsidiaries, in criminal antitrust investigations and large commercial disputes in federal and state courts and arbitration nationwide.

OVERVIEW

Co-chair of the Antitrust and Competition Law practice, Kendall Millard focuses on the resolution of complex antitrust, class action and other high-stakes commercial litigation. He represents multinational corporations, including Japanese companies and their U.S. subsidiaries, in criminal antitrust investigations and large commercial disputes in federal and state courts and arbitration nationwide.

In the white collar arena, Kendall defends clients facing large national and international criminal antitrust investigations by the U.S. Department of Justice (DOJ), the Canadian Competition Bureau (CCB), the Japan Fair Trade Commission (JFTC), the Korean Fair Trade Commission (KFTC), and the Competition Commission of Singapore (CCS). He represents many American and Japanese companies in the DOJ’s criminal antitrust investigations in the auto parts, electronic components and other industries, including obtaining a not guilty jury verdict for two Japanese clients in the only autoparts antitrust case to go to trial. He also assists clients in developing rigorous antitrust, Foreign Corrupt Practices Act (FCPA) and anti-bribery compliance programs and legal unilateral minimum advertised pricing (MAP) policies, and frequently presents antitrust compliance trainings for clients and trade associations in the U.S. and Japan.

As a civil litigator, Kendall defends clients against allegations of price fixing, bid-rigging, customer allocation, resale price maintenance, exclusive contracts, tying, bundling, boycotts, monopolization and attempted monopolization brought under Sections 1 and 2 of the Sherman Act, California’s Cartwright Act, New York’s Donnelly Act, and other state competition laws. Kendall was appointed and served as co-liaison counsel for all defendants in the In re Polyurethane Foam Antitrust Litigation, multidistrict litigation (MDL) in the Northern District of Ohio.. Kendall also advises on antitrust issues in pharmaceutical patent settlements under the Hatch-Waxman Act.

On the corporate side, Kendall advises parties and third parties concerning potential antitrust issues with proposed mergers, acquisitions and joint ventures, including in Hart-Scott-Rodino (HSR) filings before the Federal Trade Commission (FTC) and the DOJ. This includes conducting market definition and competitive impact analyses and responding to Civil Investigative Demands (CIDs) and subpoenas for documents and testimony issued to industry participants.

Kendall has published articles and contributed to ABA publications on current antitrust developments, including co-authoring the U.S. section of the ICLG International Comparative Legal Guide to Cartels and Leniency.

Clients appreciate Kendall’s extraordinary attention to their needs. He remains involved in supporting not only each client’s commercial objectives, but also in getting to know them personally. Kendall thrives under the complexity of antitrust law and other substantive legal disciplines. Kendall’s sensitivity to the major financial and other life-altering consequences that can occur in such cases drives him to educate clients before a crisis happens, as well as to aggressively defend their freedom and bottom line both in and out of court.

Kendall has represented clients on antitrust matters in a wide range of industries, including:

  • Pharmaceutical prescription and over-the-counter (OTC) products, including analgesics, opioid reversal medication, and vaccines
  • Healthcare services, including physician group practices, market power analysis for medical equipment sales to hospitals, and state action immunity for county hospitals
  • Seed and crop protection pesticide products, including seed treatment, insecticides, herbicides, fungicides, soil fumigants and nematicides
  • Ready mix concrete, aggregates, polyurethane foam, zinc oxide, exterior insulation finishing systems (EIFS), and fiberglass insulation in the construction and manufacturing industries
  • Engines, shock absorbers, sealings, resistors, latches and dozens of other component parts for automobiles, RVs, motorcycles and aircraft in the automotive, aerospace, cell phone and high-tech industries
  • Hard and soft tissue dental lasers, hospital beds, therapy and moveable medical equipment, hospital mergers, pharmaceutical distribution services, and anesthesiology services in the medical device and healthcare industries
  • Strollers, car seats, high chairs, caskets, foam mattresses and vacuum cleaners in the baby and durable consumer products industries
  • Flowers, cigarettes, kitty litter, pet food, packaged ice, bakery and other perishable food and retail products in the grocery and supermarket industry
  • Racing tires and sanctioned racing events in the sports and racing industries and gas station franchises and truck stops in the oil and gas industry
  • Software licenses and navigation systems in the computer industry and credit card issuance and data protection services in the banking industry

Notably, Kendall has also tried cases and won appeals for indigent pro bono clients seeking asylum in the U.S. to avoid persecution in their home country on account of the client’s political or religious beliefs or social group status.

Prior to joining Barnes & Thornburg, Kendall was an attorney at Arnold & Porter LLP in Washington, D.C., and at the Legal Aid Society of the District of Columbia. Prior to law school, Kendall studied and taught for three years in Japan; he is well-versed in Japanese culture and how it differs from the American point of view. He speaks conversational Japanese and taught English as a second language at IUPUI.

Professional and Community Involvement

Member, Neighborhood Christian Legal Clinic Development Committee Board of Directors

Member, American Bar Association Antitrust Section

Former adjunct professor, Indiana University Robert H. McKinney School of Law, antitrust law

Member, Power of One Board of Directors

Former board member and World Community Service Committee chair, Rotary Club of Indianapolis

Former board member and general counsel, Timmy Global Health

Graduate, Stanley K. Lacy (SKL) Executive Leadership Series

Former instructor, English as a second language, IUPUI

Member, St. Luke’s United Methodist Church

Honors

Chambers Antitrust (Indiana), 2024

The Best Lawyers in America, 2022-2025

Indiana Super Lawyers, 2017-2024

Indiana Bar Foundation Pro Bono Publico Award, 2012

Barnes & Thornburg Joseph A. Maley Pro Bono Award, 2011

 
Expereince
  • Obtained not guilty verdicts for clients Tokai Kogyo Ltd., and its U.S. subsidiary, Green Tokai Co. Ltd., in a federal criminal jury trial in the U.S. District Court for the Southern District of Ohio in Cincinnati. Tokai and Green Tokai were indicted for allegedly conspiring to fix the prices of automotive body sealing products sold to Honda in the United States and faced potential fines in the hundreds of millions of dollars. After a month-long jury trial featuring testimony from several Japanese witnesses from Nishikawa Rubber and Honda, the jury returned its verdicts after less than four hours of deliberation.
  • Defended a Japanese automobile parts manufacturer and its U.S. and Canadian subsidiaries in a global investigation of possible bid-rigging and price-fixing in the sale of auto parts to automobile manufacturers. The U.S. Department of Justice (DOJ) Antitrust Division, the Japan Fair Trade Commission, European Commission and the Canadian Competition Bureau were all involved in this investigation. After conducting a thorough internal investigation of relevant employees in the United States and Japan, and cooperating with the DOJ for more than two years, the DOJ closed its investigation of our clients. The DOJ has obtained more than $2.4 billion in criminal fines as part of its auto parts investigations to date, and the clients successfully avoided paying any fines.
  • Defended several other Japanese automobile parts and electronic component manufacturers and their U.S. subsidiaries in the DOJ Antitrust Division investigations of possible global bid rigging and price fixing. After conducting a thorough internal investigations of relevant employees in both the United States and Japan, and cooperating with the DOJ, the DOJ closed its investigation of seven of our clients.  An eighth client decided to plead guilty and pay a fine.  Represented and resolved follow-on class action and other civil antitrust litigation for all affected clients. 
  • Led subject matter teams assisting the Special Compliance Coordinator appointed by the U.S. Department of Commerce to monitor, assess and report on the U.S. export control compliance of Zhongxing Telecommunications Equipment Corporation, of Shenzhen, China, and ZTE Kangxun Telecommunications Ltd. of Hi-New Shenzhen, China (collectively, ZTE), including inspections across China, Southeast & Central Asia, Turkey, Europe, Mexico and South America.
  • Defended Flexible Foam Products, Inc., a leading producer of polyurethane foam products for bedding and other industries, to resolve without guilty plea criminal antitrust investigations by the DOJ, Canadian Bureau of Competition and EU Competition authorities. Direct and indirect purchasers of foam products thereafter filed purported class action lawsuits, in which Mr. Millard was appointed co-liaison counsel for all defendants. Barnes & Thornburg attorneys successfully settled all cases, after years of rigorous discovery, summary judgment, and trial preparation.
  • Defended a major credit card issuer in a nationwide antitrust class action arising from the shift from magnetic strip to EMV chip technology in credit cards. Plaintiffs claimed our client conspired with credit card networks and other issuing banks to shift liability for certain fraudulent credit card charges from the issuing banks to merchants accepting Visa, MasterCard, American Express and Discover credit cards. Plaintiffs filed a class action in the Northern District of California on behalf of merchants unable to accept EMV chip cards, After the Court granted a motion to dismiss with leave to amend, Mr. Millard argued to plaintiffs’ counsel how our client’s facts would not be favorable to their case, and plaintiffs voluntarily dismissed our client from the amended complaint.
  • Defended Peg Perego, a manufacturer of premium quality strollers, high chairs and car seats, in three cases alleging that baby product manufacturers conspired with Babies ‘R’ Us to impose resale pricing policies on Internet retailers in violation of Section One of the Sherman Act. Peg Perego's contribution to the class settlement amounted to less than 9 percent of the claimed single-damages against it, and later received part of the payment back after Babies ‘R’ Us went bankrupt. After Mr. Millard completed oral argument on the summary judgment motion in the remaining Internet retailer action, the plaintiffs agreed to settle the entire action and dismiss their claims with prejudice.
  • Defended authorized pharmaceutical wholesaler H.D. Smith in a nationwide antitrust lawsuit alleging defendants used FDA and state pedigree rules to exclude secondary pharmaceutical wholesalers from competing with them in violation of Sections One and Two of the Sherman Act, and New York’s Donnelly Act. The Court granted the wholesaler defendants’ motion to dismiss, with prejudice, for failure to allege a plausible conspiracy
  • Defended defendant Knauf Insulation GmbH, a leading manufacturer of fiberglass insulation, in three related antitrust actions concerning allegations of price fixing and price differentials to a major customer with alleged damages exceeding $750 million. After negotiating a cost-of-litigation settlement that was less than half the settlement of any other defendant, Mr. Millard obtained dismissal with prejudice after motions to dismiss the two indirect purchaser suits.
  • Defended global computer manufacturer/software developer in a federal antitrust lawsuit filed in the Southern District of Indiana seeking a nationwide permanent injunction against the use of the general public licensing terms for free-to-use, open source operating system software alleging Violations of Section One of the Sherman Act. The Southern District of Indiana dismissed the case for failure to adequately allege an antitrust injury, and the Seventh Circuit affirmed the dismissal.
  • Represented National Laser Technology (NLT), a seller of used dental lasers and dental laser support services, in a nationwide antitrust suit against Biolase, the country's largest manufacturer of dental lasers. NLT alleged Biolase had monopoly power in the national market for the sale of hard tissue dental lasers and used that power to coerce dentists to purchase products from it rather than from NLT in violation of Sections 1 and 2 of the Sherman Act, the Lanham Act and the California Unfair Competition Law. Obtained an early favorable settlement for client.
  • Defended Hoosier Racing Tire Corp in obtaining summary judgment in a nationwide antitrust action brought in the U.S. District Court for the Western District of Pennsylvania concerning exclusive dealing with sports sanctioning bodies. Plaintiff, a producer of racing tires, alleged that Hoosier violated the antitrust laws by entering exclusive agreements with organizations that sanction races on dirt oval tracks in the United States and Canada with a more than 70 percent share of sales The District Court granted summary judgment, and the Third Circuit upheld the dismissal in a precedential decision on appeal.
  • Represented dozens of buyers and sellers concerning antitrust and competition law aspects of large merger and acquisitions of competitors, including managing HSR filings and the resulting negotiations with the DOJ or FTC.
  • Provided antitrust advice to branded pharmaceutical manufacturers in settlements with generics in patent litigation following paragraph IV certifications under the Hatch-Waxman Act. 
 
EXPERIENCE
INSIGHTS & EVENTS
Trending Connect
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to use cookies.